Chronic Oxaliplatin-Based Chemotherapy in a Primary Ampullary Adenocarcinoma Patient without Significant Peripheral Neuropathy: Case Report and Literature Review

Peripheral neuropathy is the most common dose-limiting toxicity associated with oxaliplatin. We report on a 61-year-old female patient with advanced primary ampullary adenocarcinoma who received 35 cycles of FOLFIRINOX (5-fluorouracil, irinotecan, and oxaliplatin) chemotherapy. The patient has toler...

Descripción completa

Detalles Bibliográficos
Autores principales: Bukhari, Nedal, Winquist, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567005/
https://www.ncbi.nlm.nih.gov/pubmed/28868015
http://dx.doi.org/10.1159/000477841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567005/
https://www.ncbi.nlm.nih.gov/pubmed/28868015
http://dx.doi.org/10.1159/000477841

Ejemplares similares